Innovative Oncology Trials Radiopharm Theranostics is actively advancing novel radiopharmaceuticals for challenging cancers like prostate cancer and brain metastases, presenting opportunities to collaborate or supply specialized imaging agents and radiotherapies to oncology centers and research institutions.
Early Clinical Engagement The company's recent initiation of Phase 1 and Phase 2b clinical trials indicates a readiness to partner with healthcare providers and pharmaceutical developers to access cutting-edge diagnostic and therapeutic solutions for high unmet medical needs.
Strategic Partnerships Recent agreements with Siemens Healthineers demonstrate a proactive approach to collaboration, suggesting potential sales channels for imaging agents and diagnostic tools in the US market, targeting hospitals, imaging centers, and radiology clinics.
Growing Funding and Revenue With revenue estimates between 100 million and 250 million dollars and significant funding, Radiopharm Theranostics has resources to expand commercial distribution, creating opportunities for medical device manufacturers, distributors, and healthcare providers to integrate their innovative solutions.
Market Expansion Potential Given the company's focus on oncology radiopharmaceuticals and recent clinical successes, there are substantial prospects for sales growth into oncology clinics, research labs, and specialty hospitals seeking advanced diagnostic and treatment options for metastatic and prostate cancers.
$10B
$1B$10B
$1B$10B
$500M$1B
$1B$10B
$1B$10B
$1B$10B
$10M$25MTheranos uses 8 technology products and services including AngularJS, Moment.js, Google Maps, and more. Explore Theranos's tech stack below.
| Theranos Email Formats | Percentage |
| FLast@theranos.com | 79% |
| FirstLast@theranos.com | 16% |
| First.Last@theranos.com | 3% |
| FirLast@theranos.com | 2% |
Biotechnology ResearchCalifornia, United States51-200 Employees
About us Our mission is to make actionable information accessible to everyone at the time it matters. By making actionable information accessible to everyone in the world at the time it matters most, we are working to facilitate the early detection and prevention of disease, and empower people everywhere to live their best possible lives. Theranos is headquartered in Palo Alto, CA. https://theranos.com
Company Overview
Media & News
Funding & FinancialsTheranos has raised a total of $100M of funding over 10 rounds. Their latest funding round was raised on Dec 23, 2017 in the amount of $100M.
Theranos's revenue is estimated to be in the range of $50M$100M
Funding & FinancialsTheranos has raised a total of $100M of funding over 10 rounds. Their latest funding round was raised on Dec 23, 2017 in the amount of $100M.
Theranos's revenue is estimated to be in the range of $50M$100M
1-888-653-2347 
support@leadiq.com